{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:24:57Z","timestamp":1786933497469,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372622"],"award-info":[{"award-number":["82372622"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"DOI":"10.1186\/s13578-026-01601-3","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:36:01Z","timestamp":1781076961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ERO1L induces macrophage infiltration to potentiate KrasG12D and inflammation-induced pancreatic tumorigenesis via oxidative protein folding of CCL2"],"prefix":"10.1186","volume":"16","author":[{"given":"Junfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Heng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengkai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6870-6790","authenticated-orcid":false,"given":"Rong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"1601_CR1","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, di Magliano MP, Maitra A. Pancreatic cancer: advances and challenges. Cell. 2023;186:1729\u201354.","journal-title":"Cell"},{"key":"1601_CR2","first-page":"1561","volume":"47","author":"X Li","year":"2024","unstructured":"Li X, Hou W, Xiao C, Yang H, Zhao C, Cao D. Panoramic tumor microenvironment in pancreatic ductal adenocarcinoma. Cell Oncol (Dordrecht Netherlands). 2024;47:1561\u201378.","journal-title":"Cell Oncol (Dordrecht Netherlands)"},{"key":"1601_CR3","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/MOG.0000000000001051","volume":"40","author":"CY Jeon","year":"2024","unstructured":"Jeon CY, Arain MA, Korc M, Kozarek RA, Phillips AE. Bidirectional relationship between acute pancreatitis and pancreatic cancer. Curr Opin Gastroenterol. 2024;40:431\u20138.","journal-title":"Curr Opin Gastroenterol"},{"key":"1601_CR4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1053\/j.gastro.2018.02.011","volume":"154","author":"J Kirkegard","year":"2018","unstructured":"Kirkegard J, Cronin-Fenton D, Heide-Jorgensen U, Mortensen FV. Acute pancreatitis and pancreatic cancer risk: a nationwide matched-cohort study in Denmark. Gastroenterology. 2018;154:1729\u201336.","journal-title":"Gastroenterology"},{"key":"1601_CR5","doi-asserted-by":"crossref","unstructured":"Marstrand-Dauce L, Lorenzo D, Chassac A, Nicole P, Couvelard A, Haumaitre C. Acinar-to-ductal metaplasia (ADM): on the road to pancreatic intraepithelial neoplasia (PanIN) and pancreatic cancer. Int J Mol Sci, 2023;24(12), 994624.","DOI":"10.3390\/ijms24129946"},{"key":"1601_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ccr.2007.01.012","volume":"11","author":"C Guerra","year":"2007","unstructured":"Guerra C, Schuhmacher AJ, Canamero M, Grippo PJ, Verdaguer L, Perez-Gallego L, Dubus P, Sandgren EP, Barbacid M. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell. 2007;11:291\u2013302.","journal-title":"Cancer Cell"},{"key":"1601_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41568-020-00312-2","volume":"21","author":"X Chen","year":"2021","unstructured":"Chen X, Cubillos-Ruiz JR. Endoplasmic reticulum stress signals in the tumour and its microenvironment. Nat Rev Cancer. 2021;21:71\u201388.","journal-title":"Nat Rev Cancer"},{"key":"1601_CR8","doi-asserted-by":"crossref","unstructured":"Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol Cell. 2018;69:169\u201381.","DOI":"10.1016\/j.molcel.2017.06.017"},{"key":"1601_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41580-020-0250-z","volume":"21","author":"C Hetz","year":"2020","unstructured":"Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Bio. 2020;21:421\u201338.","journal-title":"Nat Rev Mol Cell Bio"},{"key":"1601_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13046-024-02990-4","volume":"43","author":"P Chen","year":"2024","unstructured":"Chen P, Sharma A, Weiher H, Schmidt-Wolf IGH. Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1alpha) in human cancer. J Exp Clin Cancer Res: CR. 2024;43:71.","journal-title":"J experimental Clin cancer research: CR"},{"key":"1601_CR11","doi-asserted-by":"crossref","unstructured":"Zito E, Guarrera L, Janssen-Heininger YMW. Fingerprint of the oxido-reductase ERO1: a protein disulfide bond producer and supporter of cancer. Biochim Biophys Acta Rev Cancer. 2024;1879, 189027.","DOI":"10.1016\/j.bbcan.2023.189027"},{"key":"1601_CR12","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.7150\/thno.45124","volume":"10","author":"J Zhang","year":"2020","unstructured":"Zhang J, Yang J, Lin C, Liu W, Huo Y, Yang M, Jiang S-H, Sun Y, Hua R. Endoplasmic reticulum stress-dependent expression of ERO1L promotes aerobic glycolysis in pancreatic cancer. Theranostics. 2020;10:8400\u201314.","journal-title":"Theranostics"},{"key":"1601_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1083\/jcb.201303027","volume":"202","author":"K Araki","year":"2013","unstructured":"Araki K, Iemura S, Kamiya Y, Ron D, Kato K, Natsume T, Nagata K. Ero1-alpha and PDIs constitute a hierarchical electron transfer network of endoplasmic reticulum oxidoreductases. J Cell Biol. 2013;202:861\u201374.","journal-title":"J Cell Biol"},{"key":"1601_CR14","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1074\/jbc.275.7.4827","volume":"275","author":"A Cabibbo","year":"2000","unstructured":"Cabibbo A, Pagani M, Fabbri M, Rocchi M, Farmery MR, Bulleid NJ, Sitia R. ERO1-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum. J Biol Chem. 2000;275:4827\u201333.","journal-title":"J Biol Chem"},{"key":"1601_CR15","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.4049\/jimmunol.1303228","volume":"194","author":"K Kukita","year":"2015","unstructured":"Kukita K, Tamura Y, Tanaka T, Kajiwara T, Kutomi G, Saito K, Okuya K, Takaya A, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Furuhata T, Hirata K, Sato N. Cancer-associated oxidase ERO1-alpha regulates the expression of MHC class I molecule via oxidative folding. J Immunol. 2015;194:4988\u201396.","journal-title":"J Immunol"},{"key":"1601_CR16","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.4049\/jimmunol.1402538","volume":"194","author":"T Tanaka","year":"2015","unstructured":"Tanaka T, Kajiwara T, Torigoe T, Okamoto Y, Sato N, Tamura Y. Cancer-associated oxidoreductase ERO1-alpha drives the production of tumor-promoting myeloid-derived suppressor cells via oxidative protein folding. J Immunol. 2015;194:2004\u201310.","journal-title":"J Immunol"},{"key":"1601_CR17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/bjc.2016.105","volume":"114","author":"T Tanaka","year":"2016","unstructured":"Tanaka T, Kutomi G, Kajiwara T, Kukita K, Kochin V, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Okamoto Y, Hirata K, Sato N, Tamura Y. Cancer-associated oxidoreductase ERO1-alpha drives the production of VEGF via oxidative protein folding and regulating the mRNA level. Br J Cancer. 2016;114:1227\u201334.","journal-title":"Br J Cancer"},{"key":"1601_CR18","doi-asserted-by":"publisher","first-page":"24706","DOI":"10.18632\/oncotarget.14960","volume":"8","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Kutomi G, Kajiwara T, Kukita K, Kochin V, Kanaseki T, Tsukahara T, Hirohashi Y, Torigoe T, Okamoto Y, Hirata K, Sato N, Tamura Y. Cancer-associated oxidoreductase ERO1-alpha promotes immune escape through up-regulation of PD-L1 in human breast cancer. Oncotarget. 2017;8:24706\u201318.","journal-title":"Oncotarget"},{"key":"1601_CR19","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/gutjnl-2015-310913","volume":"67","author":"B Kong","year":"2018","unstructured":"Kong B, Bruns P, Behler NA, Chang L, Schlitter AM, Cao J, Gewies A, Ruland J, Fritzsche S, Valkovskaya N, Jian Z, Regel I, Raulefs S, Irmler M, Beckers J, Friess H, Erkan M, Mueller NS, Roth S, Hackert T, Esposito I, Theis FJ, Kleeff J, Michalski CW. Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy. Gut. 2018;67:146\u201356.","journal-title":"Gut"},{"key":"1601_CR20","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1136\/gutjnl-2018-317479","volume":"68","author":"SH Jiang","year":"2019","unstructured":"Jiang SH, Zhu LL, Zhang M, Li RK, Yang Q, Yan JY, Zhang C, Yang JY, Dong FY, Dai M, Hu LP, Li J, Li Q, Wang YH, Yang XM, Zhang YL, Nie HZ, Zhu L, Zhang XL, Tian GA, Zhang XX, Cao XY, Tao LY, Huang S, Jiang YS, Hua R, Qian Luo K, Gu JR, Sun YW, Hou S, Zhang ZG. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner. Gut. 2019;68:1994\u20132006.","journal-title":"Gut"},{"key":"1601_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s13402-023-00852-3","volume":"47","author":"PC Chen","year":"2024","unstructured":"Chen PC, Ning Y, Li H, Su JG, Shen JB, Feng QC, Jiang SH, Shi PD, Guo RS. Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer. Cell Oncol. 2024;47:81\u201396.","journal-title":"Cell Oncol"},{"key":"1601_CR22","doi-asserted-by":"crossref","unstructured":"Jiang SH, Li J, Dong FY, Yang JY, Liu DJ, Yang XM, Wang YH, Yang MW, Fu XL, Zhang XX, Li Q, Pang XF, Huo YM, Li J, Zhang JF, Lee HY, Lee SJ, Qin WX, Gu JR, Sun YW, Zhang ZG. Increased serotonin signaling contributes to the Warburg effect in pancreatic tumor cells under metabolic stress and promotes growth of pancreatic tumors in mice. Gastroenterology, 2017;153:277\u2013291.","DOI":"10.1053\/j.gastro.2017.03.008"},{"key":"1601_CR23","doi-asserted-by":"crossref","unstructured":"Zhang S, Jiang LJ, Cai SQ, Weng ZQ, Zhu YH, Cai ZW, Li H, Li Q, Hu LP, Yao HF, Hua R, Zhao Y, Li DX, Yang XM, Zhang JF, Jiang SH. Vitamin D binding protein, a ligand of integrin beta 1, motivates both tumor cells and schwann cells to promote perineural invasion in pancreatic ductal adenocarcinoma. Adv Sci. 2025;12(44):e11726.","DOI":"10.1002\/advs.202511726"},{"key":"1601_CR24","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1089\/ars.2021.0018","volume":"35","author":"V Jha","year":"2021","unstructured":"Jha V, Kumari T, Manickam V, Assar Z, Olson KL, Min JK, Cho J. ERO1-PDI redox signaling in health and disease. Antioxid Redox Sign. 2021;35:1093\u2013115.","journal-title":"Antioxid Redox Sign"},{"key":"1601_CR25","doi-asserted-by":"crossref","unstructured":"Chen P, Sharma A, Weiher H, Schmidt-Wolf IGH. Biological mechanisms and clinical significance of endoplasmic reticulum oxidoreductase 1 alpha (ERO1\u03b1) in human cancer. J Exp Clin Canc Res. 2024; 43(1):71.","DOI":"10.1186\/s13046-024-02990-4"},{"key":"1601_CR26","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1042\/BST20230861","volume":"52","author":"T Pauzaite","year":"2024","unstructured":"Pauzaite T, Nathan JA. A closer look at the role of deubiquitinating enzymes in the Hypoxia Inducible Factor pathway. Biochem Soc T. 2024;52:2253\u201365.","journal-title":"Biochem Soc T"},{"key":"1601_CR27","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1038\/s41467-024-45633-0","volume":"15","author":"LL Lin","year":"2024","unstructured":"Lin LL, Wang HH, Pederson B, Wei X, Torres M, Lu Y, Li ZJ, Liu X, Mao H, Wang H, Zhou LE, Zhao Z, Sun S, Qi L. SEL1L-HRD1 interaction is required to form a functional HRD1 ERAD complex. Nat Commun. 2024;15:1440.","journal-title":"Nat Commun"},{"key":"1601_CR28","doi-asserted-by":"crossref","unstructured":"Peterson BG, Glaser ML, Rapoport TA, Baldridge RD. Cycles of autoubiquitination and deubiquitination regulate the ERAD ubiquitin ligase Hrd1, eLife. 2019;8:e509038.","DOI":"10.7554\/eLife.50903"},{"key":"1601_CR29","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.cell.2016.05.048","volume":"166","author":"RD Baldridge","year":"2016","unstructured":"Baldridge RD, Rapoport TA. Autoubiquitination of the Hrd1 ligase triggers protein retrotranslocation in ERAD. Cell. 2016;166:394\u2013407.","journal-title":"Cell"},{"key":"1601_CR30","doi-asserted-by":"publisher","first-page":"20993","DOI":"10.1074\/jbc.M110.126599","volume":"285","author":"JD Blais","year":"2010","unstructured":"Blais JD, Chin KT, Zito E, Zhang YH, Heldman N, Harding HP, Fass D, Thorpe C, Ron D. A Small molecule inhibitor of endoplasmic reticulum oxidation 1 (ERO1) with selectively reversible thiol reactivity. J Biol Chem. 2010;285:20993\u20131003.","journal-title":"J Biol Chem"},{"key":"1601_CR31","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.bmc.2019.02.016","volume":"27","author":"KE Hayes","year":"2019","unstructured":"Hayes KE, Batsomboon P, Chen WC, Johnson BD, Becker A, Eschrich S, Yang Y, Robart AR, Dudley GB, Geldenhuys WJ, Hazlehurst LA. Inhibition of the FAD containing ER oxidoreductin 1 (Ero1) protein by EN-460 as a strategy for treatment of multiple myeloma. Bioorg Med Chem. 2019;27:1479\u201388.","journal-title":"Bioorg Med Chem"},{"key":"1601_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tibs.2022.06.011","volume":"48","author":"L Wang","year":"2023","unstructured":"Wang L, Wang C-C. Oxidative protein folding fidelity and redoxtasis in the endoplasmic reticulum. Trends Biochem Sci. 2023;48:40\u201352.","journal-title":"Trends Biochem Sci"},{"key":"1601_CR33","doi-asserted-by":"publisher","first-page":"140259","DOI":"10.1016\/j.bbapap.2019.07.012","volume":"1867","author":"VA Makarov","year":"2019","unstructured":"Makarov VA, Tikhomirova NK, Savvateeva LV, Petushkova AI, Serebryakova MV, Baksheeva VE, Gorokhovets NV, Zernii EY, Zamyatnin AA Jr. Novel applications of modification of thiol enzymes and redox-regulated proteins using S-methyl methanethiosulfonate (MMTS). Biochim Biophys Acta Proteins Proteom. 2019;1867:140259.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"1601_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12885-019-5727-9","volume":"19","author":"N Takei","year":"2019","unstructured":"Takei N, Yoneda A, Kosaka M, Sakai-Sawada K, Tamura Y. ERO1alpha is a novel endogenous marker of hypoxia in human cancer cell lines. BMC Cancer. 2019;19:510.","journal-title":"BMC Cancer"},{"key":"1601_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.onc.1208325","volume":"24","author":"D May","year":"2005","unstructured":"May D, Itin A, Gal O, Kalinski H, Feinstein E, Keshet E. Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer. Oncogene. 2005;24:1011\u201320.","journal-title":"Oncogene"},{"key":"1601_CR36","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ajg.2017.218","volume":"112","author":"J Kirkegard","year":"2017","unstructured":"Kirkegard J, Mortensen FV, Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112:1366\u201372.","journal-title":"Am J Gastroenterol"},{"key":"1601_CR37","doi-asserted-by":"crossref","unstructured":"Yang JY, Xu Y, Huo YM, Cai L, Hua R, Zhang JF, Chen Z. ERO1L promotes hepatic metastasis through activating epithelial-mesenchymal transition (EMT) in pancreatic cancer. J Immunol Res. 2021;2021(1):5553425..","DOI":"10.1155\/2021\/5553425"},{"key":"1601_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/cmi.2017.135","volume":"15","author":"T Yoshimura","year":"2018","unstructured":"Yoshimura T. The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? Cell Mol Immunol. 2018;15:335\u201345.","journal-title":"Cell Mol Immunol"},{"key":"1601_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo DG, Ruffell B. Macrophages as regulators of tumour immunity and immunotherapy. Nat Rev Immunol. 2019;19:369\u201382.","journal-title":"Nat Rev Immunol"},{"key":"1601_CR40","first-page":"559","volume":"48","author":"FS Toghraie","year":"2025","unstructured":"Toghraie FS, Bayat M, Hosseini MS, Ramezani A. Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy. Cell Oncol (Dordrecht Netherlands). 2025;48:559\u201390.","journal-title":"Cell Oncol (Dordrecht Netherlands)"},{"key":"1601_CR41","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s13402-023-00824-7","volume":"46","author":"S Zhang","year":"2023","unstructured":"Zhang S, Yao HF, Li H, Su T, Jiang SH, Wang H, Zhang ZG, Dong FY, Yang Q, Yang XM. Transglutaminases are oncogenic biomarkers in human cancers and therapeutic targeting of TGM2 blocks chemoresistance and macrophage infiltration in pancreatic cancer. Cell Oncol. 2023;46:1473\u201392.","journal-title":"Cell Oncol"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-026-01601-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01601-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-026-01601-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:12:49Z","timestamp":1786932769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13578-026-01601-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1601"],"URL":"https:\/\/doi.org\/10.1186\/s13578-026-01601-3","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All research protocols involving the use of human materials were approved by the ethics committee at Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University (KY2024-102-B). All animal experimental protocols were performed following the Ethical Animal Care and Use Committee of Shanghai Jiao Tong University (202401641).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"93"}}